A high-resolution 6.0-megabase transcript map of the type 2 diabetes susceptibility region on human chromosome 20.

Recent linkage studies and association analyses indicate the presence of at least one type 2 diabetes susceptibility gene in human chromosome region 20q12-q13.1. We have constructed a high-resolution 6.0-megabase (Mb) transcript map of this interval using two parallel, complementary strategies to construct the map. We assembled a series of bacterial artificial chromosome (BAC) contigs from 56 overlapping BAC clones, using STS/marker screening of 42 genes, 43 ESTs, 38 STSs, 22 polymorphic, and 3 BAC end sequence markers. We performed map assembly with GraphMap, a software program that uses a greedy path searching algorithm, supplemented with local heuristics. We anchored the resulting BAC contigs and oriented them within a yeast artificial chromosome (YAC) scaffold by observing the retention patterns of shared markers in a panel of 21 YAC clones. Concurrently, we assembled a sequence-based map from genomic sequence data released by the Human Genome Project, using a seed-and-walk approach. The map currently provides near-continuous coverage between SGC32867 and WI-17676 ( approximately 6.0 Mb). EST database searches and genomic sequence alignments of ESTs, mRNAs, and UniGene clusters enabled the annotation of the sequence interval with experimentally confirmed and putative transcripts. We have begun to systematically evaluate candidate genes and novel ESTs within the transcript map framework. So far, however, we have found no statistically significant evidence of functional allelic variants associated with type 2 diabetes. The combination of the BAC transcript map, YAC-to-BAC scaffold, and reference Human Genome Project sequence provides a powerful integrated resource for future genomic analysis of this region.

[1]  D. Bowden,et al.  Identification and characterization of PRKCBP1, a candidate RACK-like protein , 2000, Mammalian Genome.

[2]  S. Knuutila,et al.  Chromosomal alterations in human pancreatic endocrine tumors , 2000, Genes, chromosomes & cancer.

[3]  D J Schaid,et al.  Evidence for a prostate cancer-susceptibility locus on chromosome 20. , 2000, American journal of human genetics.

[4]  P. Wang,et al.  Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map. , 2000, Genomics.

[5]  I. Wistuba,et al.  Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. , 2000, Cancer genetics and cytogenetics.

[6]  D. Bowden,et al.  Analysis of the HNF4α gene in Caucasian Type II diabetic nephropathic patients , 2000, Diabetologia.

[7]  A. Rudich,et al.  Regulation of Glucose Transporters - Implications for Insulin Resistance States , 2000, Journal of pediatric endocrinology & metabolism : JPEM.

[8]  D. Bowden,et al.  A physical map of the 20q12-q13.1 region associated with type 2 diabetes. , 1999, Genomics.

[9]  A. Henney,et al.  Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2–13.1 , 1999, Human Genetics.

[10]  B. Kahn,et al.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.

[11]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[12]  L. Kruglyak.  Prospects for whole-genome linkage disequilibrium mapping of common disease genes , 1999, Nature Genetics.

[13]  Eric Harley,et al.  Revealing hidden interval graph structure in STS-content data , 1999, Bioinform..

[14]  F. Collins,et al.  Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Bell,et al.  Genome scan for human obesity and linkage to markers in 20q13. , 1999, American journal of human genetics.

[16]  M. Petri,et al.  Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Antonellis,et al.  Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q. , 1998, Diabetes.

[18]  P. Deloukas,et al.  A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region. , 1998, Genomics.

[19]  P. Boutin,et al.  A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. , 1998, The Journal of clinical investigation.

[20]  G. Bell,et al.  Organization and Partial Sequence of the Hepatocyte Nuclear Factor-4α/MODY1 Gene and Identification of a Missense Mutation, R127W, in a Japanese Family With MODY , 1997, Diabetes.

[21]  J. Beckmann,et al.  A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. , 1997, Human molecular genetics.

[22]  Leonid Kruglyak,et al.  The use of a genetic map of biallelic markers in linkage studies , 1997, Nature Genetics.

[23]  A. M. Møller,et al.  Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4α in Caucasians with maturity onset NIDDM , 1997, Diabetologia.

[24]  S. Rich,et al.  Linkage of Genetic Markers on Human Chromosomes 20 and 12 to NIDDM in Caucasian Sib Pairs With a History of Diabetic Nephropathy , 1997, Diabetes.

[25]  S. Rich,et al.  New Susceptibility Locus for NIDDM Is Localized to Human Chromosome 20q , 1997, Diabetes.

[26]  E. Stewart,et al.  An STS-based radiation hybrid map of the human genome. , 1997, Genome research.

[27]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[28]  A. Green,et al.  DELETIONS OF CHROMOSOME 20q AND THE PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS , 1996, British journal of haematology.

[29]  D. Le Paslier,et al.  A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P M Nadkarni,et al.  CONTIG EXPLORER: interactive marker-content map assembly. , 1996, Genomics.

[31]  C. R. Kahn,et al.  Genetics of non-insulin-dependent (type-II) diabetes mellitus. , 1996, Annual review of medicine.

[32]  L Kruglyak,et al.  An STS-Based Map of the Human Genome , 1995, Science.

[33]  P. N. Rao,et al.  D20S16 is a complex interspersed repeated sequence: genetic and physical analysis of the locus. , 1995, Genomics.

[34]  A Grigoriev,et al.  Algorithms and software tools for ordering clone libraries: application to the mapping of the genome of Schizosaccharomyces pombe. , 1993, Nucleic acids research.

[35]  B. Birren,et al.  Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Woessner,et al.  Nomenclature and glossary of the matrix metalloproteinases. , 1992, Matrix (Stuttgart, Germany). Supplement.

[37]  E. Lander,et al.  Genomic mapping by anchoring random clones: a mathematical analysis. , 1991, Genomics.

[38]  R. Rizza,et al.  Effect of Insulin on Oxidation of Intracellularly and Extracellularly Derived Glucose in Patients With NIDDM: Evidence for Primary Defect in Glucose Transport and/or Phosphorylation but Not Oxidation , 1990, Diabetes.

[39]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[40]  M. Daly,et al.  A genetic linkage map of the human genome , 1987, Cell.

[41]  A. Eb,et al.  One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity. , 1986, The EMBO journal.

[42]  P. Argos,et al.  Human adenosine deaminase. cDNA and complete primary amino acid sequence. , 1984, The Journal of biological chemistry.

[43]  S. Fields,et al.  Cloning of influenza cDNA ino M13: the sequence of the RNA segment encoding the A/PR/8/34 matrix protein. , 1980, Nucleic acids research.